|
Issue |
Title |
|
Vol 12, No 3 (2024) |
Submission of Documents on the Pharmacovigilance System as Part of the Registration Dossier within the Framework of the EAEU Procedures: Analysis of Requirements and Typical Errors |
Abstract
PDF (Rus)
|
N. Yu. Velts, E. O. Zhuravleva, G. V. Kutekhova, N. V. Tereshkina |
|
Vol 12, No 3 (2024) |
Postmarketing Surveillance: Review of Open Sources of Drug Safety Data |
Abstract
PDF (Rus)
|
E. V. Shubnikova |
|
Vol 11, No 4 (2023) |
Analysis of Errors Identified during Regulatory Review of Risk Management Plans Submitted as Part of Registration Dossiers |
Abstract
PDF (Rus)
|
A. O. Lovkova, S. M. Gyulakhmedova, A. A. Druzhinina, A. A. Nekipelova |
|
Vol 11, No 1 (2023) |
Off-Label Prescribing in Paediatric Cardiology: Regulatory Aspects and Safety Assessment by Spontaneous Reporting |
Abstract
PDF (Rus)
|
E. O. Kochkina, N. V. Verlan, G. N. Kovalskaya, T. V. Tolstikova |
|
Vol 11, No 1 (2023) |
Pharmaceutical Risks of Injection Therapy: The Role of a Nurse |
Abstract
PDF (Rus)
|
S. N. Egorova, Yu. A. Abdullina |
|
Vol 10, No 4 (2022) |
Sodium Metamizole: Regulatory Status around the World, Safety Problems and Medication Errors |
Abstract
PDF (Rus)
|
E. A. Ushkalova, S. K. Zyryanov, O. I. Butranova, K. I. Samsonova |
|
Vol 10, No 4 (2022) |
Methodological Approaches to Studying Fatal Adverse Drug Reactions |
Abstract
PDF (Rus)
|
I. L. Asetskaya, V. A. Polivanov, S. K. Zyryanov |
|
Vol 10, No 4 (2022) |
Results of Surveying Cardiologists and Clinical Pharmacologists on the Selection and the Efficacy and Safety Evaluation of Pharmacotherapy for Cardiovascular Diseases |
Abstract
PDF (Rus)
|
Yu. R. Bolsunovskaya, V. V. Arkhipov |
|
Vol 10, No 1 (2022) |
Spontaneous Reporting Method Used for Safety Evaluation of Nonsteroidal Anti-Inflammatory Drugs and Paracetamol Products, Based on Assessment of Data from Periodic Reports |
Abstract
PDF (Rus)
|
A. V. Matveev, E. A. Egorova, A. E. Krasheninnikov, E. I. Konyaeva |
|
1 - 9 of 9 Items |
|